President-elect Donald Trump recently hosted Robert F. Kennedy Jr. and pharmaceutical executives for a dinner at Mar-a-Lago. Among the attendees were Pfizer CEO Albert Bourla, Eli Lilly CEO David Ricks, and PhRMA leader Steve Ubl. Discussions centered on advancing cancer research and reforming healthcare policies.
Kennedy, known for his skepticism of Big Pharma, has warned about the dangers posed by unregulated pharmaceutical companies. His role as Secretary of Health and Human Services suggests the administration plans to scrutinize corporate practices while fostering collaboration to address public health needs.
Elizabeth McDonald asks Dr. Peter McCullough
"What do you make of this, so Pfizer, Eli Lilly, big pharma execs go to Mar a Lago try to lobby Trump to ease up on them on the make America healthy again push but Trump brought RFK Jr. to the meeting what do you think of all this?"… pic.twitter.com/iy8dBSUU5f
— DrRay (@DrNoMask) December 7, 2024
The pharmaceutical sector has faced significant criticism, especially after new laws allowed Medicare to negotiate drug prices. Trump’s healthcare platform aligns with Kennedy’s call for more oversight to ensure affordability and fairness for Americans.
The meeting also included Dr. Mehmet Oz, nominated to lead Medicare and Medicaid Services. Attendees explored how government and industry partnerships could deliver on Trump’s healthcare goals, such as improving access and reducing costs.
Big Pharma Eli Lilly Announces $3B Manufacturing Expansion in Kenosha Following Strategic Meeting with Trump and RFK Jr. at Mar-a-Lago | The Gateway Pundit
Kenosha, Wisconsin, is poised for an economic revival, thanks to a groundbreaking $3 billion investment from pharmaceutical… pic.twitter.com/tqwc6e53x6
— Owen Gregorian (@OwenGregorian) December 8, 2024
By including Kennedy in discussions with pharmaceutical leaders, Trump signals a willingness to question corporate influence while leveraging industry expertise to advance medical innovation. This approach reflects a nuanced strategy to address public health challenges.
🚨Big Pharma Eli Lilly Announces $3B Manufacturing Expansion in Kenosha Following Strategic Meeting with President Trump and RFK Jr. at Mar-a-Lago
— Tiffany Hudson (@Patriot_NiNi) December 7, 2024
The Mar-a-Lago dinner highlights Trump’s commitment to creating a healthcare system that balances accountability with collaboration, ensuring both innovation and public trust.
